This list is an analysis based on recent market events. It's not an investment recommendation.
About
Glycorex Transplantation AB (publ), a medical technology company, research, develops, manufactures, markets, and sells products in the field of organ transplantation or related areas. It develops an antigen-specific immunoadsorption to reduce blood group antibodies and autoantibodies in the blood. The company's principal product is Glycosorb-ABO, which enables blood group incompatible kidney transplantation and is also used to enable heart, liver, lung, and stem cell transplantation procedures. It serves in the United Kingdom, Australia, Scandinavia, Spain, Germany, and Austria. Glycorex Transplantation AB (publ) was incorporated in 1995 and is headquartered in Lund, Sweden.
What is Glycorex Transplantation AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on London Exchange exchange Glycorex Transplantation AB stocks are traded under the ticker 0EMN.LSE.
What is Glycorex Transplantation AB revenue for the last year?▼
Glycorex Transplantation AB revenue for the last year amounts to 38.84M SEK.
What is Glycorex Transplantation AB net income for the last year?▼
0EMN.LSE net income for the last year is -7.72M SEK.
How many employees does Glycorex Transplantation AB have?▼
As of November 3, 2026, the company has 20 employees.
In which sector is Glycorex Transplantation AB located?▼
Glycorex Transplantation AB operates in the Other sector.
When did Glycorex Transplantation AB complete a stock split?▼
Glycorex Transplantation AB has not had any recent stock splits.
Where is Glycorex Transplantation AB headquartered?▼
Glycorex Transplantation AB is headquartered in Lund, Sweden.